Denise L. Blomquist - 01 Aug 2025 Form 4 Insider Report for Medtronic plc (MDT)

Role
Chief Accounting Officer
Signature
/s/ Patricia Walesiewicz, attorney-in-fact
Issuer symbol
MDT
Transactions as of
01 Aug 2025
Net transactions value
-$29,318
Form type
4
Filing time
04 Aug 2025, 16:15:29 UTC
Previous filing
30 Jul 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Blomquist Denise L. Chief Accounting Officer 710 MEDTRONIC PARKWAY, MINNEAPOLIS /s/ Patricia Walesiewicz, attorney-in-fact 04 Aug 2025 0002061393

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $0 +246 +2% $0.000000 12,671 01 Aug 2025 Direct F1
transaction MDT Ordinary Shares Tax liability $8,309 -93 -0.73% $89.34 12,578 01 Aug 2025 Direct F2
transaction MDT Ordinary Shares Options Exercise $0 +58 +0.46% $0.000000 12,636 01 Aug 2025 Direct F3
transaction MDT Ordinary Shares Tax liability $1,965 -22 -0.17% $89.34 12,614 01 Aug 2025 Direct F2
transaction MDT Ordinary Shares Tax liability $18,225 -204 -1.6% $89.34 12,410 01 Aug 2025 Direct F4
transaction MDT Ordinary Shares Options Exercise $16,692 +214 +1.7% $78.00 12,624 01 Aug 2025 Direct
transaction MDT Ordinary Shares Tax liability $17,511 -196 -1.6% $89.34 12,428 01 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Performance Share Unit Options Exercise $0 -246 -100% $0.000000 0 01 Aug 2025 Ordinary Shares 246 Direct F5, F6
transaction MDT Performance Share Unit Options Exercise $0 -58 -100% $0.000000 0 01 Aug 2025 Ordinary Shares 58 Direct F5, F6
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -214 -100% $0.000000 0 01 Aug 2025 Ordinary Shares 214 $78.00 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.
F2 Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.
F3 Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 31, 2022 and earned dividend equivalents.
F4 Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
F5 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6 The performance share units vested on August 1, 2025.
F7 These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.